Ganciclovir and maribavir cross-resistance revisited: Relative drug susceptibilities of canonical cytomegalovirus mutants. [PDF]
Antiviral ResChou S, Watanabe J.
europepmc +1 more source
Potent and sustained enhancement of human sperm motility using novel cyclic AMP upregulators. [PDF]
ReproductionOscoz-Susino N +8 more
europepmc +1 more source
Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update. [PDF]
VirusesRoyston L, Papanicolaou GA, Neofytos D.
europepmc +1 more source
Evaluation of the Effect of Maribavir on Cardiac Repolarization in Healthy Participants: Thorough QT/QTc Study. [PDF]
Clin Transl Sci, 2020 Ilic K, Song I, Wu J, Martin P.
europepmc +1 more source
In Silico Analysis of Mechanisms of Maribavir-Induced Inhibition and Drug Resistance Mutations in pUL97 Kinase Structural Prediction with AlphaFold2. [PDF]
VirusesPiret J, Boivin G.
europepmc +1 more source
Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues. [PDF]
Molecules, 2020 Papadakis G +6 more
europepmc +1 more source
Optimizing CMV therapy: Population pharmacokinetics and Monte Carlo simulations for letermovir and maribavir dosage. [PDF]
PLoS OneFromage Y +5 more
europepmc +1 more source
Current Perspectives on Letermovir and Maribavir for the Management of Cytomegalovirus Infection in Solid Organ Transplant Recipients. [PDF]
Drug Des Devel TherRazonable RR.
europepmc +1 more source
Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection. [PDF]
Antiviral Res, 2019 Chou S, Wu J, Song K, Bo T.
europepmc +1 more source
Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation. [PDF]
VirusesJaing TH, Wang YL, Chiu CC.
europepmc +1 more source